Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hawkins

Showing results (231-240 of 286) with videos related to

Pageof 29
Sort By:
AIDS (London, England)|February 3, 2016
The pharmacokinetics of abacavir 600 mg once daily in HIV-1-positive pregnant womenStein Schalkwijk, Angela Colbers, Deborah Konopnicki, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|February 23, 2013
Addressing core challenges for the next generation of type 2 translation research and systems: the translation science to population impact (TSci Impact) frameworkRichard Spoth, Louise A Rohrbach, Mark Greenberg, et al.
AIDS (London, England)|December 20, 2007
Survival following HIV infection of a cohort followed up from seroconversion in the UKFiona M Ewings, Krishnan Bhaskaran, Ken McLean, et al.
Plos One|July 31, 2015
The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UKJamie Inshaw, Clifford Leen, Martin Fisher, et al.
Evaluation Review|June 11, 2009
Design and analysis of the Community Youth Development Study longitudinal cohort sampleEric C Brown, John W Graham, J David Hawkins, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|July 6, 2013
Prevention system mediation of communities that care effects on youth outcomesEric C Brown, J David Hawkins, Isaac C Rhew, et al.
Plos One|October 3, 2013
Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failureSara Lodi, Andrew Phillips, Sarah Fidler, et al.
Bone|June 29, 2024
The complex role of Rcor2: Regulates mesenchymal stromal cell differentiation in vitro but is dispensable in vivoPetri Rummukainen, Kati Tarkkonen, Rana Al Majidi, et al.
The Journal of Antimicrobial Chemotherapy|October 19, 2014
Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant womenAngela Colbers, José Moltó, Jelena Ivanovic, et al.
Nature Communications|February 15, 2017
Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophyNiclas E Bengtsson, John K Hall, Guy L Odom, et al.
Pageof 29

Showing results (231-240 of 286) with videos related to

Sort By:
Pageof 29
AIDS (London, England)|February 3, 2016
The pharmacokinetics of abacavir 600 mg once daily in HIV-1-positive pregnant womenStein Schalkwijk, Angela Colbers, Deborah Konopnicki, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|February 23, 2013
Addressing core challenges for the next generation of type 2 translation research and systems: the translation science to population impact (TSci Impact) frameworkRichard Spoth, Louise A Rohrbach, Mark Greenberg, et al.
AIDS (London, England)|December 20, 2007
Survival following HIV infection of a cohort followed up from seroconversion in the UKFiona M Ewings, Krishnan Bhaskaran, Ken McLean, et al.
Plos One|July 31, 2015
The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UKJamie Inshaw, Clifford Leen, Martin Fisher, et al.
Evaluation Review|June 11, 2009
Design and analysis of the Community Youth Development Study longitudinal cohort sampleEric C Brown, John W Graham, J David Hawkins, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|July 6, 2013
Prevention system mediation of communities that care effects on youth outcomesEric C Brown, J David Hawkins, Isaac C Rhew, et al.
Plos One|October 3, 2013
Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failureSara Lodi, Andrew Phillips, Sarah Fidler, et al.
Bone|June 29, 2024
The complex role of Rcor2: Regulates mesenchymal stromal cell differentiation in vitro but is dispensable in vivoPetri Rummukainen, Kati Tarkkonen, Rana Al Majidi, et al.
The Journal of Antimicrobial Chemotherapy|October 19, 2014
Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant womenAngela Colbers, José Moltó, Jelena Ivanovic, et al.
Nature Communications|February 15, 2017
Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophyNiclas E Bengtsson, John K Hall, Guy L Odom, et al.
Pageof 29